VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202,449 | -29.2% | 15,279 | +0.2% | 0.00% | – |
| Q2 2023 | $285,881 | +29.7% | 15,255 | -0.2% | 0.00% | – |
| Q1 2023 | $220,424 | -11.8% | 15,286 | +110.3% | 0.00% | – |
| Q3 2022 | $250,000 | -98.4% | 7,268 | -98.9% | 0.00% | -100.0% |
| Q1 2022 | $15,738,000 | -61.8% | 690,011 | -40.7% | 0.01% | -52.9% |
| Q4 2021 | $41,239,000 | -21.4% | 1,162,796 | +0.2% | 0.02% | -26.1% |
| Q3 2021 | $52,478,000 | -34.3% | 1,160,883 | -17.9% | 0.02% | -32.4% |
| Q2 2021 | $79,847,000 | – | 1,413,771 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |